STARHEALTH - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.7
| Stock Code | STARHEALTH | Market Cap | 30,929 Cr. | Current Price | 526 ₹ | High / Low | 587 ₹ |
| Stock P/E | 55.5 | Book Value | 163 ₹ | Dividend Yield | 0.00 % | ROCE | 8.57 % |
| ROE | 6.70 % | Face Value | 10.0 ₹ | DMA 50 | 481 ₹ | DMA 200 | 466 ₹ |
| Chg in FII Hold | 0.99 % | Chg in DII Hold | -0.65 % | PAT Qtr | 111 Cr. | PAT Prev Qtr | 128 Cr. |
| RSI | 70.1 | MACD | 16.6 | Volume | 7,71,302 | Avg Vol 1Wk | 23,86,248 |
| Low price | 341 ₹ | High price | 587 ₹ | PEG Ratio | -16.1 | Debt to equity | 0.05 |
| 52w Index | 75.1 % | Qtr Profit Var | 21,731 % | EPS | 9.47 ₹ | Industry PE | 31.7 |
📊 Chart & Indicators: STARHEALTH is trading at ₹526, above both 50 DMA (₹481) and 200 DMA (₹466), confirming bullish momentum. RSI at 70.1 indicates overbought conditions, while MACD at 16.6 shows strong positive momentum. Price is consolidating between support (~₹520–₹525) and resistance (~₹570–₹580). Volume (7.7L) is significantly below weekly average (23.8L), suggesting weak participation despite strong technicals.
🎯 Entry/Exit Zones:
- Buy Zone: ₹520–₹530 (near support)
- Stop-Loss: ₹510
- Exit Levels: ₹570–₹580 (short-term resistance), ₹585–₹587 (major resistance near recent high)
📈 Trend Status: Uptrend with consolidation; price above moving averages and MACD positive, but RSI overbought and weak volume participation signal caution.
✅ Positive
- Price above both 50 DMA and 200 DMA, confirming uptrend
- EPS at ₹9.47 supports earnings visibility
- Quarterly PAT growth (+21,731%) turnaround from prior weakness
- FII holdings increased (+0.99%)
- Low debt-to-equity ratio (0.05)
⚠️ Limitation
- High P/E of 55.5 vs Industry PE 31.7 → stretched valuation
- ROE (6.70%) and ROCE (8.57%) remain modest
- RSI at 70.1 indicates overbought conditions
- Volume below weekly average, showing weak participation
- PEG ratio -16.1 indicates poor growth-adjusted valuation
📉 Company Negative News
- Quarterly PAT declined sequentially (₹128 Cr → ₹111 Cr)
- DII holdings reduced (-0.65%)
- Valuation concerns due to high P/E
📊 Company Positive News
- Strong technical momentum supported by MACD and moving averages
- FII inflows show foreign investor confidence
- 52-week index gain of 75.1%
🏦 Industry
- Industry PE at 31.7, lower than STARHEALTH’s valuation
- Insurance sector remains growth-oriented but faces margin pressures
- Regulatory challenges continue to shape profitability
📝 Conclusion
STARHEALTH is in a bullish uptrend with price above moving averages, positive MACD, and strong investor sentiment. However, stretched valuations, weak efficiency metrics, and overbought RSI limit upside potential. Best suited for swing trades with entry near ₹520–₹530 and exit around ₹570–₹580; long-term investors should remain cautious unless profitability improves and valuations moderate.
Would you like me to also generate a long-term fundamental investment rating (1–5) for STARHEALTH, so you can directly compare its technical momentum with its fundamental outlook?